May 11, 2005 (New Orleans) — Poor renal function and the nonuse of certain heart failure medications were powerful predictors of early and late mortality in patients receiving cardiac ...

MINNEAPOLIS - Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization ...

The results of COMPANION also demonstrate that CRT or CRT-D, in combination with optimal pharmacologic therapy (OPT), each respectively reduced the rate of death or hospitalization from any cause by ...

Please provide your email address to receive an email when new articles are posted on . In patients with mild HF, renal dysfunction was associated with increased risk for HF and death, but the risk ...

Amsterdam, Netherlands – 26 Aug 2023: Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodelling ...

AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

Eligible heart failure patients with a wide QRS complex spent more time alive after use of a cardiac resynchronization therapy defibrillator (CRT-D) compared with an implantable ...

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy ...

St. Jude Medical is currently conducting a pivotal U.S. clinical study, under an Investigational Device Exemption (IDE), on the MultiPoint™ CRT pacing feature. The study is evaluating outcome benefits ...

The Quadra Assura MP CRT-D is designed to work with the Quartet ™ Lead, which has four electrodes to offer maximum flexibility for different pacing configurations. The new MPP capability allows ...